Matches in Nanopublications for { ?s ?p "[Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP796984.RA__lh_N-CQ7BobKp8zoFKzJFkLaawMBGHPWmUsmSzDW4130_assertion description "[Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP796984.RA__lh_N-CQ7BobKp8zoFKzJFkLaawMBGHPWmUsmSzDW4130_provenance.
- assertion description "[Blocking biglycan-TLR2/4 interactions might be a promising strategy for the management of SLE and other B cell-mediated inflammatory disease entities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.